Lasix

Furosemide, the active ingredient in Lasix, is a loop diuretic presented as a parenteral solution for intramuscular and intravenous use. It is employed to reduce fluid overload in conditions such as congestive heart failure, liver cirrhosis, renal disease, and to help control hypertension.

GNH USA supplies Lasix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lasix (furosemide) acts on the renal loop of Henle to promote diuresis, making it useful for several fluid‑retention and blood‑pressure conditions.

- Edema associated with congestive heart failure: reduces excess fluid and eases breathing difficulty. - Edema due to liver cirrhosis: helps remove ascitic fluid and improve abdominal discomfort. - Edema due to renal disease: facilitates fluid removal when kidney function is impaired. - Hypertension: lowers blood pressure by decreasing plasma volume.

Furosemide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urinary frequency: more frequent need to void. - Electrolyte imbalance (especially low potassium): may cause muscle weakness. - Dizziness or light‑headedness: related to volume depletion. - Headache: often associated with fluid shifts. - Tinnitus: ringing in the ears, especially at high doses. - Dehydration: excessive fluid loss leading to dry mouth and thirst.

Serious or Rare Side Effects: - Severe dehydration: can cause hypotension and renal impairment. - Ototoxicity: hearing loss or persistent tinnitus, particularly with rapid IV administration. - Acute electrolyte disturbances (hypokalemia, hyponatremia): may precipitate cardiac arrhythmias. - Allergic reactions: rash, itching, or anaphylaxis. - Acute kidney injury: sudden decline in renal function.

When using Lasix, clinicians should observe several safety measures to minimize risks.

- Monitor electrolytes: check serum potassium, sodium, and magnesium regularly. - Assess renal function: evaluate creatinine and eGFR before and during therapy. - Use caution in hypotension: adjust dose or discontinue if blood pressure falls markedly. - Adjust for hepatic impairment: consider reduced dosing in patients with severe liver disease. - Avoid concurrent ototoxic drugs: limit use with aminoglycosides or high‑dose NSAIDs. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Furosemide can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Aminoglycoside antibiotics: combined use raises risk of ototoxicity. - NSAIDs: may blunt diuretic response and worsen renal function. - Lithium: furosemide can increase lithium levels, leading to toxicity. - Other loop diuretics: concurrent use can cause excessive diuresis and electrolyte loss.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, ARBs, beta‑blockers): additive blood‑pressure lowering effect. - Corticosteroids: may enhance potassium loss. - Digoxin: electrolyte shifts can predispose to digoxin toxicity. - Warfarin: furosemide may affect INR, requiring closer monitoring.